Spruce Biosciences SPRB
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 87.11 | 75.82 | -9.58 | -11,100 | -15 | |
| 2025Q3 | 8.95 | 100.44 | -14.58 | -8,229 | -8 | |
| 2025Q2 | 5.44 | 132.09 | -3.49 | -2,692 | -2 | |
| 2025Q1 | 103.48 | -24.00 | -14,492 | -14 | ||
| 2024Q4 | 102.43 | -42.72 | -24,074 | -24 | ||
| 2024Q3 | 109.40 | -15.75 | -9,408 | -9 | ||
| 2024Q2 | 110.31 | -17.25 | -10,036 | -9 | ||
| 2024Q1 | 109.59 | -21.00 | -12,633 | -12 | ||
| 2023Q4 | 113.41 | -17.25 | -11,164 | -10 | ||
| 2023Q3 | 111.63 | -22.50 | -13,658 | -12 | ||
| 2023Q2 | 110.04 | -23.25 | -13,972 | -13 | ||
| 2023Q1 | 104.26 | -30.00 | -13,199 | -13 | ||
| 2022Q4 | 109.94 | -35.25 | -12,110 | -11 | ||
| 2022Q3 | 102.36 | -36.00 | -11,557 | -11 | ||
| 2022Q2 | 100.88 | -38.25 | -11,883 | -12 | ||
| 2022Q1 | 100.50 | -37.50 | -11,733 | -12 | ||
| 2021Q4 | 100.43 | -29.25 | -9,135 | -9 | ||
| 2021Q3 | 100.36 | -0.49 | -11,400 | -11 | ||
| 2021Q2 | 100.17 | -0.51 | -11,714 | -12 | ||
| 2021Q1 | 100.19 | -0.42 | -9,817 | -10 |